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Genetic heterogeneity in tubular hypomagnesemia-hypokalemia with
hypocalciuria (Gitelman's syndrome). To better clarify the genetic inher-
itance of primary tubular hypomagnesemia-hypokalemia with hypocalci-
uria, or Gitelman's syndrome (GS), we studied eight families (10 patients
aged 11 to 22 years; 16 parents; 9 siblings) in which at least one offspring
had GS (plasma magnesium < 0.65 mmol/liter; plasma potassium < 3.6
mmol/liter; high magnesium and potassium fractional excretions; molar
urinary calcium/creatinine < 0.10). Two families each had two offspring of
different sex with GS, who all had tetanic episodes and/or marked
weakness during childhood or adolescence, whereas in three other fami-
lies two mothers and three offspring presented GS and one father and two
other offspring had hypomagnesemia and hypocalciuria but normal
plasma potassium. The mean plasma magnesium and potassium levels of
the patients of the first two families were significantly lower (P < 0.05)
than those of the other three families. Intralymphocytic but not intraeryth-
rocytic magnesium and potassium were significantly lower (P < 0.05) in
patients compared to controls, We hypothesize that there are two different
types of genetic transmission of GS, one autosomal recessive and one
autosomal dominant with high phenotypic variability. It seems that this
genetic heterogeneity is associated with a different clinical expression with
frequent tetanic episodes and lower plasma potassium and magnesium
levels in the autosomal recessive form.
Magnesium deficiency and hypocalciuria are, in addition to
hypokalemia, the biochemical hallmarks of Gitelman's syndrome
(GS), a recognized variant of Bartter's syndrome, sometimes
referred to as primary tubular hypomagnesemia-hypokalemia
with hypocalciuria [1—6]. It has been postulated that in OS the
renal tubular defect is in the distal convoluted tubule [2, 3, 5, 6],
but the exact site of the abnormality is unknown.
GS is considered to be transmitted in an autosomal recessive
fashion as suggested by the familial cases described to date [5—9].
Thus far only a few families have been studied [4—9], and
therefore to help clarify the mode of inheritance we investigated
eight families with at least one affected member.
Methods
Subjects
We studied eight families (I to VIII) in which at least one
offspring had GS. The families included 10 patients (4 males and
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6 females, aged 11 to 22 years; their 16 parents, aged 34 to 53
years; 9 siblings, 5 males and 4 females, aged 13 to 24 years). No
consanguinity was reported in the eight families. The patients'
main clinical characteristics are presented in Table 1 (the first 4
patients are 2 pairs of siblings). Four subjects had documented
tetanic episodes at first admission or subsequently. Severe weak-
ness, considered as generalized fatigue causing substantial disrup-
tion of usual daily activities, was reported in three patients (no. 1
to 3). The remaining seven patients (no. 4 to 10) had no severe
symptoms of magnesium or potassium deficiency, and GS was
only diagnosed when electrolyte measurements were performed
during investigations for mild weakness (considered as subjective
generalized fatigue without any substantial effect on usual daily
activities) associated or not with other diseases (enteritis, appen-
dicopathy, urinary tract infection). Apart from normal blood
pressure and negative screen for diuretics, the diagnosis of GS was
based on the following criteria: (1) hypomagnesemia of renal
origin, defined as plasma magnesium < 0.65 mmol/liter (by flame
atomic absorption spectrophotometry) in the presence of inap-
propriately high magnesium excretion (fractional excretion of
magnesium > 4.0%); (2) hypokalemia of renal origin, defined as
plasma potassium < 3.6 mmol/liter in the presence of inappropri-
ately high potassium excretion (fractional excretion of potassium
> 16.0%); (3) urinary calcium/creatinine molar ratio < 0.10. At
the time of the study the patients had not taken any medication
for at least one month. We also studied 13 healthy subjects aged
16 to 22 years who served as controls. No biochemical data were
available on the patients' parents or siblings at the beginning of
the study, and none of them had symptoms of any disease.
Informed consent was obtained from all the subjects studied.
Methods
Dietary records were kept by all the subjects for three days
before the study, and 24-hour urine was collected the day before.
A blood sample was taken at the end of the 24-hour urine
collection. Blood hydrogen ion concentration, blood carbon diox-
ide tension, plasma and urinary creatinine, sodium, chloride,
inorganic phosphate, total calcium and magnesium were mea-
sured in all subjects. Intralymphocytic and intraerythrocytic mag-
nesium and potassium were assayed in samples from the 10
patients, 13 parents, 8 siblings and all the controls. Blood hydro-
gen ion concentration and blood carbon dioxide tension (by
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Table 1. Main clinical data in patients with Gitelman's syndrome
Patient Sex Family
Age at
diagnosis years
Age at time
of the study
Clinical signs
Tetany Weakness
1 F I 20 22 + ++
2 M I 7 18 + ++
3 F II 12 19 — ++
4 M II 13 20 + +
5 F III 13 15 — +
6 F IV 11 16 — +
7 M V 13 14 — +
8 F VI 6 20 + +
9 F VII 6 11 — +
10 M VIII 10 16 — +
Symbols are: + +, severe weakness; +, mild weakness.
selective electrodes) were measured immediately after blood
collection. Blood was prepared for intralymphocytic and in-
traerythrocytic magnesium and potassium determinations as pre-
viously described [10]. Plasma, urinary and intracellular magne-
sium and potassium were measured by flame atomic absorption
spectrophotometry, sodium and chloride by direct flame photom-
etry, and total calcium and phosphate by colorimetry (Kodak
Ektachem). Creatinine was measured by an enzymatic method
(Hitachi 747). Plasma bicarbonate was calculated from blood
hydrogen and blood carbon dioxide tension according to the
Henderson-Hasselbach equation with an acidity exponent of 6.10
and a solubility coefficient of 0.0301. Fractional electrolyte excre-
tions were calculated using standard formulae. Creatinine clear-
ance was measured in 24-hour urines.
Statistical analysis
Data are reported as mean standard deviation (SD). Analysis
of variance was used to test differences among groups. When a
statistically significant result was found, differences between indi-
vidual means were tested using multiple comparison techniques.
A two-side P value of less than 0.05 was considered statistically
significant.
Results
The biochemical findings and the dietary habits in patients with
GS, their parents, their siblings and the control group appear in
Table 2. The four study groups did not differ with respect to
creatinine clearance, total plasma calcium, plasma and urinary
phosphate, urinary sodium excretion, and dietary intake of cal-
cium, magnesium, potassium and sodium. Apart from hypokale-
mia with inappropriate urinary potassium excretion, hypomag-
nesemia with inappropriate urinary magnesium excretion and
hypocalciuria (inclusion criteria for GS), patients with GS showed
a significant tendency to reduced plasma sodium, hypochioremia
with inappropriate urinary chloride excretion, and increased
plasma pH and bicarbonates. Mean plasma and urinary potas-
sium, sodium, chloride and magnesium, blood pH and plasma
bicarbonate were comparable in the parents, siblings and controls.
Intralymphocytic potassium was lower in the patients with respect
to the other groups and intralymphocytic magnesium was lower
only with respect to the controls (Table 3), whereas no significant
difference was found in intraerythrocytic values.
The pedigrees of the eight families and the corresponding
individual values of plasma magnesium and potassium and molar
urinary calcium creatinine are given in Figure 1. These families
were divided into three groups. Families I and II (group A) each
included 2 siblings of different sexes who had GS with a history of
tetanic episodes (patients 1, 2 and 4) and/or severe weakness
(patients 1, 2 and 3). Plasma magnesium and potassium were
normal in the four parents and the three siblings. Three families
(families III, IV and V) (group B) had one parent with all or some
of the biochemical features of GS, and the patients (no. 5, 6 and
7) presented a history of mild weakness but no tetanic episodes.
Two mothers (families IV and V) had all the biochemical features
of the syndrome, namely, hypomagnesemia, hypokalemia and
hypocalciuria. In family III the father and the two siblings had
hypomagnesemia and hypocalciuria but not hypokalemia; the
abnormalities in plasma magnesium and calciuria of both the
father and siblings were borderline compared to reference values.
None of the eight subjects with electrolyte abnormalities in group
B had major signs or symptoms attributable to hypomagnesemia
or hypokalemia. Each of the remaining three families (VI, VII
and VIII) (group C) had only one offspring with GS. Patient 8 had
a history of tetanic episodes during childhood. The remaining
members of these families had normal plasma levels and frac-
tional excretion of potassium and magnesium and a normal
urinary calcium/creatinine molar ratio.
The mean plasma levels of magnesium and potassium were
significantly lower in hypomagnesemic subjects of group A than in
those of group B (plasma magnesium, 0.40 0.9 vs. 0.57 0.07
mmol/liter; plasma potassium, 2.90 0.28 vs. 3.60 0.56
mmol/liter; P < 0.05). The mean intralymphocytic magnesium and
potassium values of the hypomagnesemic subjects of subgroup A
were slightly but not significantly lower than those of group B
(intralymphocytic magnesium 50.9 6.6 vs. 59.2 21 nmol/mg
protein; intralymphocytic potassium 441.0 66.7 vs. 517.9
123.1 nmol/mg protein). None of the other plasma, urinary and
intracellular variables differed significantly in the groups.
Discussion
This study includes the largest reported number of families with
members affected by GS. Previous reports suggested that this
disorder could have an autosomal recessive mode of inheritance
as affected siblings of different sexes have been observed with
clinically asymptomatic parents [5—91.
No information is available so far on the molecular defect of
this hereditary condition. For this reason our evaluation of the
possible mode of inheritance was based only on clinical and
biochemical data of affected patients and their relatives. Analysis
of the eight families confirmed the existence of an autosomal
recessive form of GS. In the group A families (I and II) siblings of
different sex were similarly affected. The parents of these children
were completely healthy and did not show any abnormality of
magnesium, potassium and calcium metabolism. Also in families
III, IV and V none of the parents had a clinically overt GS, but in
two mothers we found all the biochemical features of the syn-
drome. In family III the father and two siblings without any
clinical disturbance presented tubular hypomagnesemia and hy-
pocalciuria but without any hypokalemia; an X-linked recessive
transmission can be excluded in this family because of the
father-to-son transmission. The biochemical features observed in
the latter three subjects resemble those reported by Geven et al in
a renal magnesium wasting disorder with autosomal dominant
mode of inheritance in two families [11]. In family V both an
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Table 2. Biochemical findings and dietary habits in 10 patients with OS, 16 parents of patients with GS, 9 siblings of patients with OS, and a
control group of 13 healthy subjects
Patients Siblings Parents Controls
Creatinine clearance ml/min/1,73 m2 119 31 111 39 109 28 119 24
Plasma K mmol/liter 3.0 0.3" 4.3 0.2 4.2 0.3 4.2 0.3
FEK, % 20.0 3.6" 9.1 3.2 9.9 5.1 9.6 3.2
Plasma Na mmol/liter 137.0 1.4 139.2 1.8 140.1 1.7 139.5 1.9
FENa, % 1.1 0.3 0.8 0.5 0.9 0.3 0.9 0.4
Plasma Cl mmol/liter 94.9 2.4" 100.8 1.9 101.9 1.6 101.8 2.0
FEc1, % 1.7 0.5" 1,2 0.6 1.2 0.3 1.2 0.5
Venous pH 7.422 0.03? 7.340 0.039 7.383 0.026 7.346 0.034
Plasma HC03 mmol/liter
Tot plasma Mg mmol/liter
FEMg %
32.0 2.3a
0.48 0.11"
6.7 2.D
28.0 1.8
0.75 0.07
3.6 1.1
27.6 2.2
0.75 0.12
2.8 0.9
28.0 1.8
0.74 0.04
3.0 0.6
Tot plasma Ca, mmol/liter
Molar Ucaicr
2.46 0.06
0.030 0.017"
2.46 0.05
0.224 0.129
2.37 0.04
0.286 0.171
2.41 0.11
0.384 0.220
Plasma P04, mmol/liter 1.26 0.16 1.39 0.18 1.10 0.13 1.20 0.13
TRP, % 87.3 4.9 88.1 2.9 84.8 5.3 85.9 2.2
Dietary Ca, intake mg/day 616 233 622 337 772 473 607 477
Dietary Mg, intake mg/day 236 114 219 49 256 105 212 58
Dietary K, intake mg/day 2779 644 2227 644 2422 916 2073 592
Dietary Na, intake mg/day 1756 718 1473 346 2063 997 1446 729
Data are mean so. Abbreviations are: FE, fractional excretion; TRP, tubular reabsorption of phosphate.
"P C 0.05, patients vs. controls, parents, and siblings, respectively
b Not compared in the patients and controls; a significant difference was predictable as the value was by definition abnormal in a patient with OS
Table 3. Magnesium and potassium levels in lymphocytes and
erythrocytes of the four study groups
Patients
(N=10) Siblings(N=8)
Parents
(N=13)
Controls
(N=8)
Lymphocyte magnesium 55 9" 64 15 63 15 66 9
nmol/mg protein
Lymphocyte potassium 459 77" 568 76 542 68 534 95
nmol/mg protein
Erythrocyte magnesium 1.9 0.2 2.1 0.3 2.1 0.2 2.0 0.2
mmol/liter
Erythrocyte potassium 76 4 74 8 76 5 78 7
mmol/Iiter
Data are mean SD.
"p C 0.05 patients vs. controls, parents and siblings, respectively
"P C 0.05 patients vs. all other groups
autosomal dominant and an X-linked recessive mode of transmis-
sion with clinical expression in the carrier may be postulated. In
family IV the mode of inheritance seems autosomal dominant
although X-linked recessive transmission could not be formally
excluded. In our opinion, taking all these data together, the most
likely hypothesis appears to be that OS was transmitted in
autosomal dominant fashion with highly variable clinical expres-
sion in the group B families.
In our OS patients with recessive mode of inheritance the
clinical features were severe and included both muscular weak-
ness and tetany. In those with a hypothesized dominant transmis-
sion the clinical features of OS were mild, including muscular
weakness but without tetany, and mean plasma and magnesium
levels were significantly higher than in the patients with autosomal
recessive mode of inheritance (group A). Furthermore, as in most
disorders with this pattern of inheritance, the clinical and bio-
chemical expression of OS was highly variable in our patients with
hypothesized dominant inheritance. In families VI, VII and VIII
(group C) only one offspring was affected and the biochemical
evaluation of the parents did not show any specific abnormality
related to OS. These families do not afford useful information on
the mode of transmission of the disease because this situation
could be explained both as a new mutation of an autosomal
dominant gene and as homozygosity for an autosomal recessive
form.
Our study also provides some new data on the biochemical and
intracelluar alterations in OS. Experimental hypomagnesemia
promotes both tubular calcium reabsorption and potassium de-
pletion [12—14], whereas elevated extracellular magnesium results
in an inhibition of tubular calcium reabsorption [14]. It has
therefore been suggested that in OS hypokalemia and hypocalci-
uria are secondary to hypomagnesemia [5]. We observed asymp-
tomatic hypomagnesemia and hypocalciuria without any associ-
ated hypokalemia in three healthy members of a family with
dominantly transmitted OS. We speculate that in OS both hypo-
magnesemia and hypocalciuria may precede potassium deficiency.
Not surprisingly, therefore, correction of hypomagnesemia in OS
corrects only the tendency to potassium deficiency [5] without any
consistent influence on urinary calcium excretion [3], indicating
that hypomagnesemia is not the cause of hypocalciuria [3].
However, the pathogenesis of OS is still unclear and this sugges-
tion needs further evaluation.
Muscular weakness and tetanic episodes, the main clinical
features of OS, have been imputed not only to hypokalemia and
hypomagnesemia but also to a reduced skeletal muscle content of
the mentioned ions [15, 16]. Intracellular values of magnesium
and potassium, which have not previously been investigated in GS,
were depleted in our patients, at least as far as lymphocytic
content is concerned. Intralymphocytic magnesium has been
demonstrated to correlate well with the cation content in muscle
and bone [17, 18], two compartments containing 80% of whole
body magnesium [19, 20]. Other studies have shown that in-
traerythrocytic magnesium and potassium do not reflect intracel-
lular content as intralymphocytic content [10, 18], and this may
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explain the absence of intraerythrocytic differences between our
patients and the other groups studied.
In conclusion, our data in eight families provide evidence for a
genetic heterogeneity of GS with the existence of at least two
different forms: one with autosomal recessive inheritance present-
ing with frequent tetanic episodes and lower plasma potassium
and magnesium levels, and a new one with autosomal dominant
inheritance presenting only with mild muscular weakness or even
without any symptoms. It is relatively rare but not unknown for
the same disease to be transmitted in both dominant and recessive
fashions, and molecular biology studies are required to resolve
this question.
Reprint requests to Alberto Bettinelli, M.D., Dialisi Infantile, Clinica
Pediatrica de Marchi, Via Commenda 9, 20122, Milano, Italy.
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